✦ LIBER ✦

Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia

✍ Scribed by Suat-Cheng Peh; Gin-Gin Gan; Lin-Kiat Lee; Geok-Im Eow

Book ID: 115175964
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 354 KB
Volume: 58
Category: Article
ISSN: 1320-5463
DOI: 10.1111/j.1440-1827.2008.02273.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Coexpression of Bcl-6 and CD10 in diffus

Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: Significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma

✍ Howe J Ree; Woo Ick Yang; Chul Woo Kim; Jooryung Huh; Seung-Sook Lee; Eun Yoon C 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 327 KB

Expression profile of CD10, Bcl-6, CD138

Expression profile of CD10, Bcl-6, CD138, Bcl-2 and MUM1 and their prognostic value in 136 patients with diffuse large B-cell lymphoma

✍ Yan Song; Zhi Cao; Qin Su; Ling Li; Hongtu Zhang; Yuankai Shi; Xun Zhang 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 587 KB

Pathogenetic and clinical implications o

Pathogenetic and clinical implications of Bcl-6 and Bcl-2 gene configuration in nodal diffuse large B-cell lymphomas

✍ Pescarmona, Edoardo; De Sanctis, Vitaliana; Pistilli, Alessandra; Pacchiarotti, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Bcl-6 (LAZ-3) and Bcl-2 gene rearrangements have been respectively reported in 20-35 per cent and 10-25 per cent of diffuse large B-cell lymphomas (DLBCLs). Although these genetic lesions have been associated with different clinical outcomes (i.e., more favourable in Bcl-6 rearranged cases and poore

Low incidence of BCL-6 gene alterations

Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan Chinese

✍ Po-Min Chen; Muh-Hwa Yang; I-Ting Yu; Jen-Tsun Lin; Yu-Chen Lin; Frank S. Fan; W 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB

## Abstract ## BACKGROUND In Western populations, rearrangement of the __BCL__‐6 gene can be identified in 20–40% of patients with diffuse large B‐cell lymphoma (DLBCL). Analysis of the __BCL__‐6 gene has revealed the presence of point mutations or small deletions in 70% of DLBCL tumors; however,

New chromosome abnormalities and lack of

New chromosome abnormalities and lack of BCL-6 gene rearrangements in Argentinean diffuse large B-cell lymphomas

✍ Roxana Cerretini; Maria F. Noriega; Marina Narbaitz; Irma Slavutsky 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB

Prognostic value of bcl-6, CD10 and CD38

Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I–II gastric lymphomas: Identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome

✍ Maurilio Ponzoni; Andrés J.M. Ferreri; Giancarlo Pruneri; Barbara Pozzi; Stefani 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB

## Abstract bcl‐6, CD10 and CD38 are useful markers for identifying 2 molecularly and prognostically distinct profiles of diffuse large B‐cell lymphomas (LCLs), defined as germinal‐center B‐like and activated B‐like. We investigated the prognostic role of bcl‐6, CD10 and CD38 immunoreactivity in 10